Hairy cell leukemia management and outcome with cladribine (2- chlorodeoxyadenosine) treatment activity and toxicity / Tarek Yakout Mohamed ; Supervised Ola Mohamed Reda Khorshid , Alfred Elias Namour , Mosaad Mahmoud Elgammal

By:

Tarek Yakout Mohamed

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Tarek Yakout Mohamed , 2013Description: 98 P. : charts , facsimiles ; 25cmOther title:

العلاج بعقار الكلادريبين ونتائجه فى مرضى سرطان الدم ذو الخلية المشعرة نتائج العلاج والأعراض الجانبية [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical) Summary: Hairy cell leukemia (HCL) is rare B- cell lymphoproliferative disorder . Its treatment has evolved from splenectomy with time to failure (TTF) of 19 months to cladribine that increased complete remission (CR) rate to 90% with only small percentage of patients relapsing at 30 months . Cladribine (CDA) is originally administered intravenously as continuous infusion for 7 days

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.M.Sc.2013.Ta.H (Browse shelf(Opens below))		Not for loan		01010110062873000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.19.04.M.Sc.2013.Ta.H (Browse shelf(Opens below))	62873.CD	Not for loan		01020110062873000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.19.04.M.Sc.2013.Sh.P Patterns of failure after surgery for differentiated thyroid cancer and factors associated with recurrence and persistence of disease /	Cai01.19.04.M.Sc.2013.Sh.P Patterns of failure after surgery for differentiated thyroid cancer and factors associated with recurrence and persistence of disease /	Cai01.19.04.M.Sc.2013.Ta.H Hairy cell leukemia management and outcome with cladribine (2- chlorodeoxyadenosine) treatment activity and toxicity /	Cai01.19.04.M.Sc.2013.Ta.H Hairy cell leukemia management and outcome with cladribine (2- chlorodeoxyadenosine) treatment activity and toxicity /	Cai01.19.04.M.Sc.2013.Ya.P Primary resection versus early staged resection within one week (quasi-single stage) for acute obstructing colorectal cancer /	Cai01.19.04.M.Sc.2013.Ya.P Primary resection versus early staged resection within one week (quasi-single stage) for acute obstructing colorectal cancer /	Cai01.19.04.M.Sc.2014.Ah.R Response criteria to induction chemotherapy as a prognostic factor for adult acute myeloid leukemia : Retrospective study of national cancer institute cases of year, 2009. /	Next

Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology (Medical)

Hairy cell leukemia (HCL) is rare B- cell lymphoproliferative disorder . Its treatment has evolved from splenectomy with time to failure (TTF) of 19 months to cladribine that increased complete remission (CR) rate to 90% with only small percentage of patients relapsing at 30 months . Cladribine (CDA) is originally administered intravenously as continuous infusion for 7 days

Issued also as CD

There are no comments on this title.

to post a comment.